These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20202516)

  • 1. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
    Liuni A; Luca MC; Gori T; Parker JD
    J Am Coll Cardiol; 2010 Mar; 55(10):1002-6. PubMed ID: 20202516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.
    Liuni A; Luca MC; Gori T; Parker JD
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H153-8. PubMed ID: 22003053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study.
    Gori T; Sicuro S; Dragoni S; Donati G; Forconi S; Parker JD
    Circulation; 2005 Feb; 111(6):742-6. PubMed ID: 15699265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.
    Liuni A; Luca MC; Gori T; Parker JD
    Clin Hemorheol Microcirc; 2010; 45(2-4):161-7. PubMed ID: 20675896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.
    Wouters CW; Wever KE; Bronckers I; Hopman MT; Smits P; Thijssen DH; Rongen GA
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):22-8. PubMed ID: 21885990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effects of exenatide on endothelial dysfunction induced by ischemia-reperfusion injury via KATP channels.
    Ha SJ; Kim W; Woo JS; Kim JB; Kim SJ; Kim WS; Kim MK; Cheng XW; Kim KS
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):474-80. PubMed ID: 22155457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibition and rosuvastatin-induced vascular protection in the setting of ischemia-reperfusion: A human in vivo study.
    Kwong W; Liuni A; Zhou K; Parker JD
    Vascul Pharmacol; 2015 Aug; 71():159-65. PubMed ID: 25869511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postconditioning protects against endothelial ischemia-reperfusion injury in the human forearm.
    Loukogeorgakis SP; Panagiotidou AT; Yellon DM; Deanfield JE; MacAllister RJ
    Circulation; 2006 Feb; 113(7):1015-9. PubMed ID: 16476844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute administration of either amiloride or captopril does not prevent endothelial dysfunction induced by ischemia and reperfusion in the human forearm vasculature.
    Luca MC; Liuni A; DiFabio J; Gori T; Parker JD
    Can J Physiol Pharmacol; 2010 Oct; 88(10):996-1001. PubMed ID: 20962899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight.
    Gori T; Di Stolfo G; Sicuro S; Dragoni S; Lisi M; Forconi S; Parker JD
    Br J Clin Pharmacol; 2007 Aug; 64(2):145-50. PubMed ID: 17324239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
    Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily ischemic preconditioning provides sustained protection from ischemia-reperfusion induced endothelial dysfunction: a human study.
    Luca MC; Liuni A; McLaughlin K; Gori T; Parker JD
    J Am Heart Assoc; 2013 Feb; 2(1):e000075. PubMed ID: 23525419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).
    ter Avest E; Abbink EJ; Holewijn S; de Graaf J; Tack CJ; Stalenhoef AF
    Curr Med Res Opin; 2005 Sep; 21(9):1469-76. PubMed ID: 16197666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
    Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
    Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
    Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y
    Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin preconditions postischemic arterial endothelial function in humans.
    Liuba P; Batra S; Pesonen E; Werner O
    J Card Surg; 2005; 20(5):420-4. PubMed ID: 16153271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postconditioning fails to prevent radial artery endothelial dysfunction induced by ischemia and reperfusion: evidence from a human in vivo study.
    Dragoni S; Di Stolfo G; Sicuro S; Lisi M; Parker JD; Forconi S; Gori T
    Can J Physiol Pharmacol; 2006 Jun; 84(6):611-5. PubMed ID: 16900245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
    Lu TM; Ding YA; Leu HB; Yin WH; Sheu WH; Chu KM
    Am J Cardiol; 2004 Jul; 94(2):157-61. PubMed ID: 15246890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.